Human bocavirus: As an emerging respiratory pathogen
View abstract on PubMed
Summary
This summary is machine-generated.Human bocavirus (HBoV) causes respiratory and gastrointestinal infections, primarily in young children. Diagnosis relies on molecular methods, with symptomatic treatment and general preventive measures recommended due to lack of specific antivirals or vaccines.
Area Of Science
- Virology and Epidemiology
- Pediatric Infectious Diseases
Background
- Acute respiratory infections (ARIs) are a leading cause of global morbidity and mortality, particularly in children.
- Human bocavirus (HBoV), a non-enveloped DNA virus, is increasingly recognized as a significant respiratory pathogen in infants and young children.
- HBoV is also detected in the gastrointestinal tract, indicating a broader spectrum of infection.
Purpose Of The Study
- To review the current understanding of human bocavirus (HBoV) virology, epidemiology, and clinical significance.
- To discuss diagnostic approaches and current management strategies for HBoV infections.
- To highlight the challenges in determining HBoV's exact pathogenic role due to co-infections.
Main Methods
- Literature review of studies on HBoV.
- Analysis of epidemiological data on HBoV prevalence across different age groups.
- Summary of clinical presentations and diagnostic techniques, including molecular methods for viral DNA detection.
Main Results
- HBoV1 infection prevalence ranges from 10.3% to 12.51% in children under 3 years.
- Clinical manifestations span from mild upper RTIs to severe pneumonia and multi-organ failure, with increased risk in children with pre-existing conditions.
- HBoV is frequently detected alongside other respiratory viruses, complicating the assessment of its sole etiological role.
Conclusions
- HBoV is an important cause of respiratory tract infections in children, with varied clinical severity.
- Current management is symptomatic, as no specific antiviral treatments or vaccines are available.
- Further research is needed to clarify the precise pathogenic role of HBoV, especially in the context of co-infections.
Related Concept Videos
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Viral Recombination Can Create New Diseases
Some diseases can infect multiple species. For example, pigs can be infected by some human and...
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
The pathophysiology of pneumonia involves the following steps:
• Inhalation of Infectious Agents: Pneumonia typically begins when pathogenic organisms (bacteria, viruses, fungi) are inhaled or aspirated into the lower respiratory tract.
• Overcoming Lung Defenses: Ideally, the respiratory tract has defense mechanisms like mucociliary clearance and cough reflex to prevent the establishment of pathogenic organisms. If these defenses are compromised, or the pathogen is highly...
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

